ORI
AGIO icon

Oak Ridge Investments’s Agios Pharmaceuticals AGIO Stock Holding History

Oak Ridge Investments’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$841K Buy
24,865
+4,861
+24% +$138K 0.06% 131
2025
Q4 		$545K Sell
20,004
-5,381
-21% -$189K 0.03% 146
2025
Q3 		$1.02M Sell
25,385
-11,867
-32% -$446K 0.07% 120
2025
Q2 		$1.24M Sell
37,252
-1,835
-5% -$55.6K 0.09% 109
2025
Q1 		$1.15M Buy
39,087
+218
+0.6% +$7.23K 0.1% 109
2024
Q4 		$1.28M Sell
38,869
-1,509
-4% -$70.9K 0.1% 107
2024
Q3 		$1.79M Buy
40,378
+5,142
+15% +$234K 0.16% 93
2024
Q2 		$1.52M Sell
35,236
-4,807
-12% -$173K 0.14% 100
2024
Q1 		$1.17M Buy
+40,043
New +$1.07M 0.12% 115

Other funds holding AGIO

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return